Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dividends vs Share Buyback

Dividends give a nice quick pop but share buyback are a longer lasting impact to share price. Hindsight being that perfect 20-20 tells us how much better off we would have been if all the money spent for M&A and dividends were spent in reducing float. That would be crying over spilt milk. What do we do for the present course of action.

Never saw any followup to WOLF's open letter to BOD. Did I miss it?

What course of action would motivate PTSC towards more transparancy towards retail shareholders? We have people from all walks of life on this board and we can't seem to get together on a course of action for the betterment of our investment.

Share
New Message
Please login to post a reply